0001209191-20-008895.txt : 20200212
0001209191-20-008895.hdr.sgml : 20200212
20200212172432
ACCESSION NUMBER: 0001209191-20-008895
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200210
FILED AS OF DATE: 20200212
DATE AS OF CHANGE: 20200212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20605629
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-10
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Controller
Common Stock
2020-02-10
4
F
0
4673
240.95
D
25550
D
Common Stock
2020-02-11
4
S
0
380
243.59
D
25170
D
Common Stock
2020-02-11
4
S
0
1560
244.90
D
23610
D
Common Stock
2020-02-11
4
S
0
1700
245.89
D
21910
D
Common Stock
2020-02-11
4
S
0
1120
246.84
D
20790
D
Common Stock
2020-02-11
4
S
0
1102
247.93
D
19688
D
Common Stock
169
I
401(k)
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $243.59 (range $243.29 to $244.28).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $244.90 (range $244.37 to $245.33).
Open market sales reported on this line occurred at a weighted average price of $245.89 (range $245.39 to $246.30).
Open market sales reported on this line occurred at a weighted average price of $246.84 (range $246.46 to $247.38).
Open market sales reported on this line occurred at a weighted average price of $247.93 (range $247.58 to $248.55).
/s/ Omar White, Attorney-in-Fact
2020-02-12